PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Genetics strongly impacts the course of metabolic dysfunction-associated steatotic liver disease (MASLD), with the I148M <i>Patatin like phospholipase domain containing 3</i> (<i>PNPLA3</i>) variant representing the main modifier.